Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of Japanese encephalitis infections.
A new commercial enzyme-linked immunosorbent assay (ELISA) for the diagnosis of Japanese encephalitis virus infections showed a sensitivity of 88% with sera and 81% with cerebrospinal fluid and a specificity of 97% with sera from patients with primary and secondary dengue virus infections. Specificity was 100% when samples from nonflavivirus infections were tested.
Cuzzubbo
A J
AJ
PanBio Pty. Ltd., Windsor, Brisbane, Queensland, Australia.
Endy
T P
TP
Vaughn
D W
DW
Solomon
T
T
Nisalak
A
A
Kalayanarooj
S
S
Dung
N M
NM
Warrilow
D
D
Aaskov
J
J
Devine
P L
PL
D000914:Antibodies, Viral / Q000097:blood / Q000134:cerebrospinal fluid; D003715:Dengue / Q000175:diagnosis / Q000276:immunology; D004664:Encephalitis Virus, Japanese / Q000276:immunology; D004672:Encephalitis, Japanese / Q000175:diagnosis* / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods* / Q000706:statistics & numerical data; D005069:Evaluation Studies as Topic; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood / Q000134:cerebrospinal fluid; D012680:Sensitivity and Specificity
D000914:Antibodies, Viral; D007075:Immunoglobulin M